A detailed history of Simplex Trading, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 11,996 shares of HRTX stock, worth $21,232. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,996
Previous 95,631 87.46%
Holding current value
$21,232
Previous $334,000 93.11%
% of portfolio
0.0%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$1.73 - $3.67 $144,688 - $306,940
-83,635 Reduced 87.46%
11,996 $23,000
Q2 2024

Jul 25, 2024

BUY
$2.32 - $3.86 $221,863 - $369,135
95,631 New
95,631 $334,000
Q4 2023

Feb 02, 2024

BUY
$0.54 - $1.82 $11,122 - $37,488
20,598 New
20,598 $35,000
Q2 2023

Aug 04, 2023

BUY
$1.11 - $2.88 $8,281 - $21,487
7,461 Added 423.2%
9,224 $10,000
Q1 2023

Apr 27, 2023

SELL
$1.51 - $3.25 $40,576 - $87,334
-26,872 Reduced 93.84%
1,763 $2,000
Q4 2022

Feb 02, 2023

BUY
$2.25 - $4.67 $16,899 - $35,076
7,511 Added 35.56%
28,635 $71,000
Q3 2022

Nov 04, 2022

BUY
$2.66 - $5.37 $5,913 - $11,937
2,223 Added 11.76%
21,124 $89,000
Q2 2022

Aug 03, 2022

BUY
$2.3 - $6.29 $43,472 - $118,887
18,901 New
18,901 $52,000
Q1 2022

May 02, 2022

SELL
$4.63 - $9.94 $179,889 - $386,198
-38,853 Closed
0 $0
Q4 2021

Feb 23, 2022

BUY
$8.35 - $12.6 $307,672 - $464,272
36,847 Added 1836.84%
38,853 $354,000
Q3 2021

Oct 28, 2021

BUY
$10.13 - $15.0 $20,320 - $30,090
2,006 New
2,006 $30,000
Q2 2021

Aug 12, 2021

SELL
$13.27 - $18.48 $850,646 - $1.18 Million
-64,103 Closed
0 $0
Q1 2021

Apr 26, 2021

BUY
$14.49 - $20.72 $928,852 - $1.33 Million
64,103 New
64,103 $1.04 Million
Q4 2020

Feb 02, 2021

SELL
$14.61 - $22.14 $113,154 - $171,474
-7,745 Closed
0 $0
Q3 2020

Oct 14, 2020

BUY
$13.67 - $17.77 $104,739 - $136,153
7,662 Added 9231.33%
7,745 $114,000
Q2 2020

Jul 13, 2020

SELL
$10.89 - $21.47 $568,153 - $1.12 Million
-52,172 Reduced 99.84%
83 $1,000
Q1 2020

Apr 29, 2020

BUY
$10.23 - $24.56 $401,056 - $962,850
39,204 Added 300.39%
52,255 $613,000
Q4 2019

Feb 05, 2020

SELL
$17.42 - $26.61 $560,296 - $855,884
-32,164 Reduced 71.14%
13,051 $306,000
Q3 2019

Oct 15, 2019

BUY
$16.36 - $21.39 $420,321 - $549,551
25,692 Added 131.6%
45,215 $836,000
Q2 2019

Jul 26, 2019

BUY
$16.93 - $26.22 $175,919 - $272,452
10,391 Added 113.79%
19,523 $362,000
Q1 2019

Apr 18, 2019

BUY
$23.15 - $28.34 $135,890 - $166,355
5,870 Added 179.95%
9,132 $0
Q4 2018

Jan 16, 2019

BUY
$22.03 - $32.01 $17,646 - $25,640
801 Added 32.55%
3,262 $84,000
Q3 2018

Oct 23, 2018

SELL
$30.0 - $40.85 $1.06 Million - $1.45 Million
-35,489 Reduced 93.52%
2,461 $77,000
Q2 2018

Jul 30, 2018

BUY
$26.4 - $42.0 $793,082 - $1.26 Million
30,041 Added 379.83%
37,950 $1.47 Million
Q1 2018

Apr 26, 2018

BUY
$18.43 - $28.8 $145,762 - $227,779
7,909 New
7,909 $218,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $210M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.